Cargando…
多西他赛与吉非替尼序贯应用对人肺腺癌细胞SPC-A1生长及信号蛋白的影响
BACKGROUND AND OBJECTIVE: It has been proven that chemotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) could not increase response for advanced non-small cell lung cancer (NSCLC), but its cellular mechanism was not well known. The aim of this study is to...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000335/ https://www.ncbi.nlm.nih.gov/pubmed/21569641 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.05.01 |
Ejemplares similares
-
多西他赛与吉非替尼序贯应用对人肺腺癌细胞H1975存活及凋亡通路的研究
Publicado: (2012) -
雷公藤甲素与吉非替尼序贯应用对人肺腺癌细胞H1975存活及凋亡通路的影响
Publicado: (2015) -
晚期非小细胞肺癌RRM1蛋白表达与吉西他滨联合顺铂化疗疗效的关系
Publicado: (2011) -
基于代谢组学的多西他赛调控肺癌细胞代谢重编程研究
Publicado: (2019) -
小剂量多西他赛持续化疗联合树突状细胞生物免疫治疗抑制VEGF分泌
Publicado: (2013)